Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00326352
Status:
TERMINATED
Last Update Posted:
2006-05-16
First Post:
2006-05-15
Brief Title:
Comparison of SedationAnalgesia MidazolamMorphine Vs PropofolRemifentanil
Sponsor:
University of Edinburgh
Organization:
University of Edinburgh
Study Overview
Official Title:
Comparison of SedationAnalgesia MidazolamMorphine Vs PropofolRemifentanil
Status:
TERMINATED
Status Verified Date:
2006-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
For reduction of dislocated shoulder sedation with propofol and remifentanil should give satisfactory operating conditions and pain relief and significantly reduce the time to full recovery compared with morphine and midazolam
Detailed Description:
Propofol is a recognised agent for sedation and remifentanil is a short acting opioid analgesic We intend to provide sedation with propofol 05 mgKg and analgesia with remifentanil 05 microgramKg for reduction of dislocated shoulders This will be a randomised sex-stratified comparison with current therapy which is midazolam incrementally up to a maximum of 015 mgKg and morphine incrementally up to 015 mgKg The primary outcome measure is time to full recovery Secondary aspects are pain or discomfort during the procedure and operating conditions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None